Anabolic Steroids Market Size

  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Anabolic Steroids Market Size

Anabolic Steroids Market size was valued at USD 16.42 billion in 2024 and is set to exceed USD 55.36 billion by 2037, registering over 9.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anabolic steroids is evaluated at USD 17.71 billion.. As the number of elderly people increases, so does the market for anabolic steroids. People 60 years of age and older will outnumber children under five by 2023.Eighty percent of the elderly worldwide will reside in low- and middle-income nations by 2050. The rate of population aging is far faster than it used to be. Furthermore, the anabolic steroids market is expanding as men's weight issues get worse.

In addition to these, the list of uses for androgens and anabolic steroids may grow in the future. Their potential application in the management of a number of illnesses, including osteoporosis, disorders involving the breakdown of muscle, and several hormone imbalances, is still being investigated. Furthermore, creating new, practical delivery methods for androgens and anabolic steroids like long-acting injectables or transdermal patches can enhance patient compliance and the therapy process as a whole.


Anabolic Steroids Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5986
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of anabolic steroids is evaluated at USD 17.71 billion.

The anabolic steroids market size was valued at USD 16.42 billion in 2024 and is set to exceed USD 55.36 billion by 2037, registering over 9.8% CAGR during the forecast period i.e., between 2025-2037. Increasing geriatric population and prevalence of hypogonadism in men will drive the market growth.

North America industry is expected to account for largest revenue share of 33% by 2037, impelled by increasing incidence of breast cancer in the region.

The major players in the market include Mylan N.V., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Johnson & Johnson Private Limited, Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd., Merck & Co., Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample